Tissue Regenix Group plc Accounts Payable

Tissue Regenix Group plc (TSSNF) currently reports a accounts payable of $2.7M as of December 2024. That compares with $1.2M in the prior-year period — up 124.9% year over year. Use the charts on this page to explore Tissue Regenix Group plc's accounts payable history and peer comparisons.

Tissue Regenix Group plc's accounts payable increased from $1.2M to $2.7M — a 124.9% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tissue Regenix Group plc reported $2.7M in accounts payable as of December 2024. That compares with $1.2M in the prior-year period — up 124.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $2.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tissue Regenix Group plc, and consider following TSSNF for alerts when major investors trade the stock.